Clinical Trial Update: TCR-T Cell Therapy on Advanced Solid Tumors [EARLY_Phase 1]

View source ↗

Summary

Phase 1 TCR-T cell therapy for pancreatic cancer is currently recruiting at Sun Yat-Sen Memorial Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• TCR-T cell therapy (T-cell receptor-engineered T cells)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Pancreatic Cancer | EARLY_Phase 1 | Status: RECRUITING